Real Clinics. Real Patients. Real Oncology.

Image without description (no attachment ID found)

MD Anderson researchers showed investigational NTX-301 stayed active in resistant AML by reactivating the Hippo pathway.

July 27, 2026

Trending

Stay ahead in oncology

Weekly breakthroughs, expert insights, and clinical updates.

Our Insights

Articles, expert reviews, and opinion pieces from our leaders out in the field and treating populations

View More

In Your Practice

Community Practices Cite Cost, Need for Prospective Data as Barriers to Biomarker Testing in Endometrial Cancer

Biomarker-guided treatment is improving endometrial cancer outcomes, but community practices still face gaps in molecular testing and subtype-driven care.

July 17, 2026

Watch Now

Listen Now

Cancer, Clearly
our flagship podcast
Image without description (no attachment ID found)
Episode 3
Inside Oncology Revenue Cycle Management: A Conversation with Kem Tolliver, BS, FACMPE, CPC, CMOM

In this episode, we sit down with Kem Tolliver, President and CEO of Medical Revenue Cycle Specialists and a nationally recognized expert in practice management and revenue cycle optimization, to unpack why oncology’s financial infrastructure is uniquely complex and why getting it right directly impacts patient access and outcomes. From denial prevention to workflow redesign, Kem shares actionable insights every oncology leader should hear.

July 14, 2026

Oncology is evolving.   Stay current.  

Weekly breakthroughs, expert insights, and clinical updates —delivered to your inbox.

What are you
looking for?

POPULAR SEARCHES